Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00109135 | A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007) | PHASE2 | COMPLETED | 300 | — | — | Jan 1, 2005 | Jun 1, 2005 | Sep 25, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| taranabant | DRUG | - |
Inclusion Criteria: * Smoking greater than/equal to 10 cigarettes/day for at least 1 year * Laboratory tests that meet the criteria of the study * In overall good health as determined by the investigator Exclusion Criteria: * Psychiatric diagnoses * Certain cancers * Patients who use nicotine rep...